Cancer stem cells are thought to share many characteristics with their normal stem cell counterparts, raising concerns about the ability to selectively target them. A new study shows that Dclk1 marks cancer, but not normal, stem cells in the intestine and that targeting this population results in adenoma collapse without affecting normal tissue.
References
Clevers, H. Nat. Med. 17, 313–319 (2011).
Nakanishi, Y. et al. Nat. Genet. 45, 98–103 (2013).
May, R. et al. Stem Cells 26, 630–637 (2008).
Gerbe, F., Brulin, B., Makrini, L., Legraverend, C. & Jay, P. Gastroenterology 137, 2179–2180 (2009).
Barker, N. et al. Nature 449, 1003–1007 (2007).
Schepers, A. G. et al. Science 337, 730–735 (2012).
Polakis, P. Curr. Opin. Pharmacol. 5, 382–387 (2005).
Tian, H. et al. Nature 478, 255–259 (2011).
Chen, J. et al. Nature 488, 522–526 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors are employees of Genentech, Inc., and F.J.d.S. owns shares of Roche.
Rights and permissions
About this article
Cite this article
Metcalfe, C., de Sauvage, F. A tumor-specific stem cell. Nat Genet 45, 7–9 (2013). https://doi.org/10.1038/ng.2502
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.2502
- Springer Nature America, Inc.
This article is cited by
-
Suppressing STAT5 signaling affects osteosarcoma growth and stemness
Cell Death & Disease (2020)